COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.720
-0.040 (-1.45%)
Feb 21, 2025, 4:00 PM EST - Market closed

COSCIENS Biopharma Market Cap

COSCIENS Biopharma has a market cap or net worth of $10.55 million as of February 21, 2025. Its market cap has increased by 21.30% in one year.

Market Cap
10.55M
Enterprise Value
-6.93M
1-Year Change
21.30%
Ranking
Category
Stock Price
2.72

Market Cap Chart

Since December 31, 2001, COSCIENS Biopharma's market cap has decreased from $167.20M to $10.55M, a decrease of -93.69%. That is a compound annual growth rate of -11.25%.

History

DateMarket Cap% Change
Feb 21, 20258.50M-1.16%
Dec 31, 20248.60M-4.44%
Dec 29, 20239.00M-41.56%
Dec 30, 202215.40M-64.27%
Dec 31, 202143.10M61.42%
Dec 31, 202026.70M78.00%
Dec 31, 201915.00M-68.94%
Dec 31, 201848.30M58.36%
Dec 29, 201730.50M-14.57%
Dec 30, 201635.70M1,131.03%
Dec 31, 20152.90M-89.34%
Dec 31, 201427.20M-22.29%
Dec 31, 201335.00M-15.87%
Dec 31, 201241.60M-67.60%
Dec 30, 2011128.40M18.34%
Dec 31, 2010108.50M152.91%
Dec 31, 200942.90M65.00%
Dec 31, 200826.00M-68.25%
Dec 31, 200781.90M-61.96%
Dec 29, 2006215.30M-7.56%
Dec 30, 2005232.90M-17.99%
Dec 31, 2004284.00M133.74%
Dec 31, 2003121.50M16.49%
Dec 31, 2002104.30M-37.62%
Dec 31, 2001167.20M-
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 784.71B
UnitedHealth Group 429.24B
Novo Nordisk 391.83B
Johnson & Johnson 390.76B
AbbVie 356.74B
Abbott Laboratories 234.01B
AstraZeneca 229.50B
Merck & Co. 226.40B
Market Cap Rankings